Zimmer Biomet's SVP and CHRO sold $251K of Zimmer Biomet shares. Nobody planned it ahead of time.
Traded Feb 12, 2026 · Filed Feb 17, 2026
Zimmer Biomet's Group President, Asia Pacific sold $96K of Zimmer Biomet shares. It happened by itself, for taxes or pay.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$96,490
Shares × reported transaction price
2 days after results of Feb 10, 2026, 75 days before results of Apr 28, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $95.18 on Feb 12, 2026, 11% above its 52-week low and 16% below its high, after a 5% rise over the previous 30 trading days
52-week range $85.71 (Jan 28, 2026) to $113.18 (Mar 31, 2025), 34% of the way up, from 251 adjusted closes. 30 trading days earlier: $90.79 on Dec 30, 2025. Describes the past only, not a forecast
Footnote references an employee stock purchase plan
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +1.6% | +1.0% | +0.6% |
| 30 days | -10.6% | -5.5% | -5.1% |
| 90 days | -12.4% | +6.9% | -19.3% |
| 180 days | -0.1% | +12.6% | -12.6% |
Past results only. Not a forecast.
Zimmer Biomet's SVP and CHRO sold $251K of Zimmer Biomet shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.